Related Experiment Videos

Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease

C Hurabielle1, F Sicre de Fontbrune2, H Moins-Teisserenc3,4

  • 1Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.

The British Journal of Dermatology
|April 20, 2017
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos